Literature DB >> 18071264

Lithospermi radix extract inhibits histamine release and production of inflammatory cytokine in mast cells.

Eun Kyoung Kim1, Eun-Young Kim, Phil-Dong Moon, Jae-Young Um, Hyung-Min Kim, Hyun-Sam Lee, Youngjoo Sohn, Seong Kyu Park, Hyuk-Sang Jung, Nak-Won Sohn.   

Abstract

Lithospermi radix (LR, Borraginaceae, the root of Lithospermum erythrorhizon Siebold. et Zuccarinii) is used in herbal medicine to treat such conditions as eczema, skin burns and frostbite. This study investigates the effects of LR on the anti-allergy mechanism. LR inhibited the release of histamine from rat peritoneal mast cells by compound 48/80 in a dose-dependent manner. LR orally administered at 6.59 mg/100 g also inhibited the anti-DNP IgE-induced passive cutaneous anaphylaxis reaction. LR inhibited the PMA plus A23187-induced increase in IL-6, IL-8, and TNF-alpha expression in HMC-1 cells. In addition, LR also inhibited nuclear factor-kappa B (NF-kappaB) activation and I kappaB-alpha degradation. These results show that LR had an inhibitory effect on the atopic allergic reaction. Furthermore, the in vivo and in vitro anti-allergic effect of LR suggests possible therapeutic applications of this agent for inflammatory allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071264     DOI: 10.1271/bbb.70208

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

Review 1.  Oral Administration of East Asian Herbal Medicine for Inflammatory Skin Lesions in Plaque Psoriasis: A Systematic Review, Meta-Analysis, and Exploration of Core Herbal Materials.

Authors:  Hee-Geun Jo; Hyehwa Kim; Donghun Lee
Journal:  Nutrients       Date:  2022-06-12       Impact factor: 6.706

2.  Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.

Authors:  Zafar Rasheed; Nahid Akhtar; Arivarasu N Anbazhagan; Sangeetha Ramamurthy; Meenakshi Shukla; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.